Tyrosine hydroxylase (TH)-expressing interneurons are a specialized population of catecholaminergic neurons found primarily in the striatum, olfactory bulb, and hippocampus[1]. Unlike the major dopaminergic projection neurons of the substantia nigra pars compacta and ventral tegmental area, these interneurons are local circuit neurons that synthesize and release dopamine within their resident structures[2]. They represent a numerically small but functionally critical population that modulates local circuit dynamics and network excitability.
In the striatum, TH-expressing interneurons constitute approximately 0.5-1% of all striatal neurons but serve as the sole intrinsic source of dopamine within this structure[3]. Their strategic positioning and unique physiological properties allow them to provide rapid, spatially restricted dopaminergic signaling that complements the volume transmission from nigrostriatal projection neurons.
| Property | Value |
|---|---|
| Primary Locations | Striatum, olfactory bulb (granule cell layer), hippocampus |
| Cell Type | Aspinous or sparsely spiny interneurons |
| Estimated Population | ~8,000-15,000 in human striatum (0.5-1% of striatal neurons) |
| Primary Neurotransmitter | Dopamine (inhibitory via D2 receptors) |
| Key Markers | TH+, DAT-, VMAT2+, GABA+ (subset) |
| Firing Pattern | Low-threshold calcium spike (LTS) bursts, spontaneous firing |
| Functional Role | Local dopamine modulation, feedforward inhibition, reward signaling |
Striatal TH interneurons exhibit distinctive morphological features [4]:
| Marker | Expression | Functional Significance |
|---|---|---|
| Tyrosine Hydroxylase (TH) | High | Rate-limiting enzyme for dopamine synthesis |
| Dopamine Transporter (DAT) | Low/Absent | Distinguishes from nigrostriatal projection neurons |
| VMAT2 (SLC18A2) | Present | Packages dopamine into vesicles |
| Aromatic L-amino acid decarboxylase (AADC) | Present | Converts L-DOPA to dopamine |
| D2 Dopamine Receptor | High | Autoreceptor function |
| GABA | Subset (~50%) | Some co-release GABA |
| Parvalbumin | Absent | Distinguishes from PV+ interneurons |
| Somatostatin | Absent | Distinguishes from SST+ interneurons |
Striatal TH interneurons differ from nigral dopaminergic neurons in several key aspects [5]:
Striatal TH interneurons exhibit unique electrophysiological characteristics [6]:
TH interneurons receive diverse synaptic inputs[7]:
TH interneurons provide rapid, spatially restricted dopaminergic signaling[8]:
| Striatal Cell Type | TH Interneuron Effect | Receptor Mediation |
|---|---|---|
| D1-MSNs (direct pathway) | Weak excitation or neutral | D1 receptor (Gs-coupled) |
| D2-MSNs (indirect pathway) | Inhibition | D2 receptor (Gi-coupled) |
| Cholinergic interneurons | Inhibition | D2 receptor |
| Other interneurons | Variable | Multiple receptor types |
The fate of striatal TH interneurons in PD is complex and potentially compensatory[9]:
Striatal TH interneurons represent potential targets for cell therapy[10]:
| Approach | Rationale | Status |
|---|---|---|
| D2 receptor modulation | Enhance autoreceptor feedback | Standard antipsychotics affect this |
| TH upregulation | Increase local dopamine synthesis | Research stage |
| GABA-dopamine co-release | Target dual transmission | Research stage |
| Gene/Protein | Symbol | Function | Disease Relevance |
|---|---|---|---|
| Tyrosine Hydroxylase | TH | Rate-limiting enzyme in dopamine synthesis | PD: Primary marker for dopaminergic neurons |
| Aromatic L-amino acid decarboxylase | DDC | Converts L-DOPA to dopamine | PD: Target for L-DOPA therapy |
| Dopamine receptor D2 | DRD2 | Autoreceptor on TH interneurons | PD: Target of antipsychotics |
| Vesicular monoamine transporter 2 | SLC18A2 | Packages dopamine into vesicles | PD: PET imaging target |
| T-type calcium channel | CACNA1H | Generates low-threshold spikes | Epilepsy: Burst firing regulation |
| Glutamate decarboxylase | GAD1 | GABA synthesis (subset) | Neurological disorders |
Betarbet R, et al. Dopaminergic neurons intrinsic to the primate striatum. Journal of Neuroscience. 1997. ↩︎
Dubach M, et al. Primate neostriatal neurons containing tyrosine hydroxylase: immunohistochemical evidence. Neuroscience Letters. 1987. ↩︎
Palfi S, et al. Phenotypic characterization of dopaminergic neurons in the primate striatum. Journal of Neural Transmission. 2001. ↩︎
Mura A, et al. Morphological and electrophysiological characteristics of tyrosine hydroxylase immunoreactive neurons in the rat striatum. Neuroscience. 2000. ↩︎
Iribe Y, et al. Dopaminergic modulation of striatal interneurons and circuit function. Neuroscience. 2019. ↩︎
Bracci E, et al. Spontaneous and evoked activity of striatal dopaminergic interneurons. Journal of Neurophysiology. 2002. ↩︎
Koshiya N, et al. Intracortical inputs to striatal interneurons and their modulation by dopamine. Synapse. 1999. ↩︎
Yamin HG, et al. Striatal medium spiny neurons: electrophysiological properties and role in behavior. Journal of Neurophysiology. 2019. ↩︎
Huot P, et al. The characteristics of striatal dopaminergic neurons in Parkinson's disease. Progress in Brain Research. 2015. ↩︎
Adler AF, et al. Generation of human striatal interneurons from pluripotent stem cells. Cell Reports. 2019. ↩︎